Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study
Authors:
- Hartmut LinkHLHartmut Link
- Wolfgang HiddemannWHWolfgang Hiddemann
- Peter MeyerPMPeter Meyer
- Dieter AdamDADieter Adam
Open Access
Abstract
Background. Different empirical approaches to antimicrobial treatment of lung infiltrates in patients with neutropenia were studied within a prospective, randomized multicenter trial. Methods. Patients with neutropenia with hematologic malignancies and fever of 38.5°C or higher associated with newly diagnosed lung infiltrates were randomized for an initial therapy with acylaminopenicillin plus aminoglycoside (Group A), third‐generation cephalosporin plus aminoglycoside (Group B), or the double β‐lactam combination (Group C), each in combination with rifampin. Nonresponders were given empirical amphotericin B plus 5‐fluorocytosine beginning on day 4, day 5, or day 6 under study. Results. Of 295 patients entered, 91.2% were evaluable. Complete response was obtained in 61.3% with no significant difference between treatment groups. The addition of rifampin did not improve treatment results. Only 27.1% of patients achieved a complete response by antibiotic therapy without additional antifungal therapy. Fungi dominated in cases of microbiologically documented infections and were associated with a poorer outcome compared with bacterial pneumonias. The trend of leukocyte counts under study had a highly significant effect on the outcome of infection. Conclusions. Lung infiltrates in febrile patients with neutropenia represent a high risk of treatment failure. Persistent neutropenia has a significantly adverse effect on the outcome of infection. Incorporation of systemic antifungal agents into first‐line therapy, particularly in selected high‐risk subgroups, might improve future treatment results. The quality of diagnostic techniques to establish the etiology of pulmonary infiltrates needs to be improved.Keywords
This publication has 69 references indexed in Scilit:
- Outcome of Respiratory Failure in Hematologic MalignancyChest, 1988
- Adult Respiratory Distress Syndrome in Patients with Severe NeutropeniaNew England Journal of Medicine, 1986
- Adult respiratory distress syndrome in neutropenic patientsThe American Journal of Medicine, 1986
- Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritisThe American Journal of Medicine, 1986
- Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis.Journal of Clinical Oncology, 1985
- New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibioticsThe Pediatric Infectious Disease Journal, 1984
- Treatment of respiratory infections in the patient at riskThe American Journal of Medicine, 1984
- Opportunistic fungal infections in patients with neoplastic diseaseThe American Journal of Medicine, 1984
- Fungal infections in patients with acute leukemiaThe American Journal of Medicine, 1982
- Pulmonary Infiltrates in LeukemiaChest, 1980